Siemens Healthineers testosterone test receives CDC certification
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/20/2026
- Wall Street gains ground on healthcare stocks rally, oil retreat
- Brent slips as Iran president discusses mediation with Pakistan army chief
- Loop Capital downgrades Apple, sees no recovery of cut iPhone shipments
- Wells Fargo says S&P 500 buy signal emerges as investors turn excessively bearish
- ByteDance, Alibaba and Tencent order $35 billion of Nvidia chips: Reuters
- Cerebras Systems falls as TD Cowen cuts price target
- Nasdaq climbs as chip and AI-linked stocks bounce back
- Flutter Entertainment to cut up to 1,400 jobs amid UK tax increases
- 3M issues warrant to Amazon in $6B data center product deal
- Glass House Brands posts Q3 revenue of $56.8M, board member exits
CDC HoST-TT Certification for Siemens Healthineers Total Testosterone Test Expands Patient Access to Gold Standard Equivalent Results
May 4, 2026 9:30 AM EDTTarrytown, NY, USA, May 04, 2026 (GLOBE NEWSWIRE) --
The Atellica TSTII Testosterone assay is the only immunoassay with CDC HoST-TT CertificationCertification reaffirms assay results are aligned with specialized mass spectrometry testing methodThe immunoassay test is a broadly available, economical option for patients and laboratoriesSiemens Healthineers announced its Atellica IM Testosterone II (TSTII) assay has achieved certification through the Centers for Disease Control and Prevention (CDC) Hormone Standardization Program for Total Testosterone (HoSt-TT). This certifies that the Atellica IM TSTII immunoassays test results are... More



